- Clinical Trials
- April 2024
- 40 Pages
Global
From €1188EUR$1,250USD£998GBP
- Report
- May 2024
- 133 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- May 2022
- 170 Pages
Global
From €2377EUR$2,500USD£1,997GBP
The Immune Disorders Drugs market includes drugs used to treat inflammatory pain. These drugs are used to reduce inflammation and pain caused by a variety of conditions, including arthritis, lupus, and psoriasis. They work by blocking the production of certain chemicals that cause inflammation and pain. Commonly used drugs in this market include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and biologics. NSAIDs are the most commonly used drugs, as they are effective in reducing inflammation and pain. Corticosteroids are used to reduce inflammation and pain in more severe cases, while biologics are used to treat autoimmune diseases.
Some companies in the Immune Disorders Drugs market include Pfizer, Merck, AbbVie, and Johnson & Johnson. Show Less Read more